New Drugs Target Immune-System Ills A new generation of drugs for arthritis, skin diseases and other immune-system disorders is on the way to consumers. Trial versions of the drugs, known as "biologic modifiers," are helping many people who've had no luck with standard drugs in treating chronic and sometimes debilitating diseases. Hear NPR's Richard Knox.
NPR logo

New Drugs Target Immune-System Ills

  • Download
  • <iframe src="https://www.npr.org/player/embed/1513228/1513229" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
New Drugs Target Immune-System Ills

New Drugs Target Immune-System Ills

New Drugs Target Immune-System Ills

  • Download
  • <iframe src="https://www.npr.org/player/embed/1513228/1513229" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

A new generation of drugs for arthritis, skin diseases and other immune-system disorders is on the way to consumers. Trial versions of the drugs, known as "biologic modifiers," are helping many people who've had no luck with standard drugs in treating chronic and sometimes debilitating diseases. Hear NPR's Richard Knox.